These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 22534075)
1. Reliability of KRAS mutation testing in metastatic colorectal cancer patients across five laboratories. Feigelson HS; Goddard KA; Johnson MA; Funk KC; Rahm AK; Kauffman TL; Chitale DA; Le Marchand L; Richards CS BMC Res Notes; 2012 Apr; 5():196. PubMed ID: 22534075 [TBL] [Abstract][Full Text] [Related]
2. A comparability study of 5 commercial KRAS tests. Oliner K; Juan T; Suggs S; Wolf M; Sarosi I; Freeman DJ; Gyuris T; Baron W; Bakker A; Parker A; Patterson SD Diagn Pathol; 2010 Apr; 5():23. PubMed ID: 20398393 [TBL] [Abstract][Full Text] [Related]
3. KRAS and BRAF mutation analysis in colorectal adenocarcinoma specimens with a low percentage of tumor cells. Lewandowska MA; Jóźwicki W; Żurawski B Mol Diagn Ther; 2013 Jun; 17(3):193-203. PubMed ID: 23606169 [TBL] [Abstract][Full Text] [Related]
4. Analytical performance of a PCR assay for the detection of KRAS mutations (codons 12/13 and 61) in formalin-fixed paraffin-embedded tissue samples of colorectal carcinoma. Lee S; Brophy VH; Cao J; Velez M; Hoeppner C; Soviero S; Lawrence HJ Virchows Arch; 2012 Feb; 460(2):141-9. PubMed ID: 22173329 [TBL] [Abstract][Full Text] [Related]
5. KRAS analysis in colorectal carcinoma: analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice. Sundström M; Edlund K; Lindell M; Glimelius B; Birgisson H; Micke P; Botling J BMC Cancer; 2010 Dec; 10():660. PubMed ID: 21122130 [TBL] [Abstract][Full Text] [Related]
6. Comparison of COBAS 4800 KRAS, TaqMan PCR and high resolution melting PCR assays for the detection of KRAS somatic mutations in formalin-fixed paraffin embedded colorectal carcinomas. Harlé A; Busser B; Rouyer M; Harter V; Genin P; Leroux A; Merlin JL Virchows Arch; 2013 Mar; 462(3):329-35. PubMed ID: 23400679 [TBL] [Abstract][Full Text] [Related]
7. Metastatic colorectal cancer KRAS genotyping in routine practice: results and pitfalls. Lamy A; Blanchard F; Le Pessot F; Sesboüé R; Di Fiore F; Bossut J; Fiant E; Frébourg T; Sabourin JC Mod Pathol; 2011 Aug; 24(8):1090-100. PubMed ID: 21516079 [TBL] [Abstract][Full Text] [Related]
8. Detection of KRAS codon 12 and 13 mutations by mutant-enriched PCR assay. Chang YS; Er TK; Lu HC; Yeh KT; Chang JG Clin Chim Acta; 2014 Sep; 436():169-75. PubMed ID: 24863805 [TBL] [Abstract][Full Text] [Related]
9. Sensitive multiplex detection of KRAS codons 12 and 13 mutations in paraffin-embedded tissue specimens. Laosinchai-Wolf W; Ye F; Tran V; Yang Z; White R; Bloom K; Choppa P; Labourier E J Clin Pathol; 2011 Jan; 64(1):30-6. PubMed ID: 21030527 [TBL] [Abstract][Full Text] [Related]
10. High sensitivity of reverse-hybridization methodology in the detection of KRAS mutations from formalin-fixed paraffin-embedded colorectal cancer samples. De Miglio MR; Mura A; Uras MG; Manca A; Contini M; Murgia L; Zinellu A; Sotgia S; Carru C; Massarelli G; Cossu-Rocca P Diagn Mol Pathol; 2010 Dec; 19(4):201-8. PubMed ID: 21052001 [TBL] [Abstract][Full Text] [Related]
11. Sensitive detection of KRAS mutations in archived formalin-fixed paraffin-embedded tissue using mutant-enriched PCR and reverse-hybridization. Ausch C; Buxhofer-Ausch V; Oberkanins C; Holzer B; Minai-Pour M; Jahn S; Dandachi N; Zeillinger R; Kriegshäuser G J Mol Diagn; 2009 Nov; 11(6):508-13. PubMed ID: 19797612 [TBL] [Abstract][Full Text] [Related]
12. Mutation analysis of BRAF exon 15 and KRAS codons 12 and 13 in Moroccan patients with colorectal cancer. Bennani B; Gilles S; Fina F; Nanni I; Ibrahimi SA; Riffi AA; Nejjari C; Benajeh DA; El Abkari M; Martin PM; Ouafik L Int J Biol Markers; 2010; 25(4):179-84. PubMed ID: 21161938 [TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of colorectal cancer (CRC) in reference to KRAS proto-oncogene utilizing WAVE technology. Perez K; Walsh R; Brilliant K; Noble L; Yakirevich E; Breese V; Jackson C; Chatterjee D; Pricolo V; Roth L; Shah N; Cataldo T; Safran H; Hixson D; Quesenberry P Exp Mol Pathol; 2013 Aug; 95(1):74-82. PubMed ID: 23528430 [TBL] [Abstract][Full Text] [Related]
14. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas]. Zhang X; Wang Y; Gao N; Wang J Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565 [TBL] [Abstract][Full Text] [Related]
15. Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer. Neumann J; Zeindl-Eberhart E; Kirchner T; Jung A Pathol Res Pract; 2009; 205(12):858-62. PubMed ID: 19679400 [TBL] [Abstract][Full Text] [Related]
16. Implementation of formalin-fixed, paraffin-embedded cell line pellets as high-quality process controls in quality assessment programs for KRAS mutation analysis. Dijkstra JR; Opdam FJ; Boonyaratanakornkit J; Schönbrunner ER; Shahbazian M; Edsjö A; Hoefler G; Jung A; Kotsinas A; Gorgoulis VG; López-Ríos F; de Stricker K; Rouleau E; Biesmans B; van Krieken JH J Mol Diagn; 2012; 14(3):187-91. PubMed ID: 22414609 [TBL] [Abstract][Full Text] [Related]
17. Companion-diagnostic testing limited to KRAS codons 12 and 13 misses 17% of potentially relevant RAS mutations in colorectal cancer. Netzel BC; Grebe SK Clin Chim Acta; 2013 Oct; 425():1-2. PubMed ID: 23832066 [TBL] [Abstract][Full Text] [Related]
18. KRAS and BRAF mutation analysis can be reliably performed on aspirated cytological specimens of metastatic colorectal carcinoma. Pang NK; Nga ME; Chin SY; Ismail TM; Lim GL; Soong R; Salto-Tellez M Cytopathology; 2011 Dec; 22(6):358-64. PubMed ID: 21029218 [TBL] [Abstract][Full Text] [Related]
19. The importance of evaluation of DNA amplificability in KRAS mutation testing with dideoxy sequencing using formalin-fixed and paraffin-embedded colorectal cancer tissues. Okayama N; Nishioka M; Hazama S; Sakai K; Suehiro Y; Maekawa M; Sakamoto J; Iwamoto S; Kato T; Mishima H; Oka M; Hinoda Y Jpn J Clin Oncol; 2011 Feb; 41(2):165-71. PubMed ID: 20926413 [TBL] [Abstract][Full Text] [Related]
20. Validation of companion diagnostic for detection of mutations in codons 12 and 13 of the KRAS gene in patients with metastatic colorectal cancer: analysis of the NCIC CTG CO.17 trial. Harbison CT; Horak CE; Ledeine JM; Mukhopadhyay P; Malone DP; O'Callaghan C; Jonker DJ; Karapetis CS; Khambata-Ford S; Gustafson N; Trifan OC; Chang SC; Ravetto P; Iv GA Arch Pathol Lab Med; 2013 Jun; 137(6):820-7. PubMed ID: 23030695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]